PlainRecalls
FDA Drug Low Class III Ongoing

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

Reported: October 22, 2025 Initiated: October 9, 2025 #D-0025-2026

Product Description

FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.

Reason for Recall

Labeling: Incorrect or Missing Lot and/or Exp Date

Details

Recalling Firm
STAQ Pharma, Inc.
Distribution
Nationwide in the U.S.
Location
Denver, CO

Frequently Asked Questions

What product was recalled?
FentaNYL Citrate PF, 500mcg/50 mL (10mcg/mL) in NACL, Injection for IV use, 50 mL syringe, STAQ Pharma Inc., 14135 E 42nd Ave, Denver, Colorado, NDC 73177-0102-05.. Recalled by STAQ Pharma, Inc..
Why was this product recalled?
Labeling: Incorrect or Missing Lot and/or Exp Date
Which agency issued this recall?
This recall was issued by the FDA Drug on October 22, 2025. Severity: Low. Recall number: D-0025-2026.